PREVENALC: Guided Self-Change Prevention Program for Alcohol Abuse in Adolescents in Educational Settings
Study Details
Study Description
Brief Summary
This study corresponds to a pretest-posttest randomized experimental design with two arms. Arm 1 includes Guided Self-Change program, and Arm 2 a psychoeducational program to promote healthy habits. This study aims to analyze the efficacy of a selective and indicated prevention program based on the Guided Self-Change model (GSC) in adolescent alcohol users between 16-18 years. Researchers hypothesize that implementation of GSC therapy will lead to a greater reduction of alcohol drinkers compare with the control condition, and will prevent alcohol abuse after 6 and 12 months.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Guided Self-Change therapy
|
Behavioral: Guided Self-Change therapy (GSC)
The GSC program follows a motivational cognitive-behavioral approach designed to minimize resistance in drug behavior changes, prevent relapse risk, and increase motivation to quit. The GSC consists of 5 weekly sessions of 50 minutes delivered in groups of 20-25 people.
|
Active Comparator: Psychoeducation program about healthy habits
|
Behavioral: Psychoeducation program about healthy habits
The psychoeducational program will include talks about healthy habits such as physical activity, relaxation, and sleep hygiene. This intervention consists of 5 weekly sessions of 50 minutes delivered in groups of 20-25 people.
|
Outcome Measures
Primary Outcome Measures
- Alcohol use change [Change from baseline up to 5 weeks and two follow-ups at 6 and 12 months post intervention]
Alcohol use will be assessed using the Timeline Follow-Back (Sobell & Sobell, 1992)
- Alcohol abuse [Change from baseline to week 5, and at 6 and 12 months post intervention.]
Alcohol abuse will be assessed using the Rutgers Alcohol Problem Index (White & Labouvie, 1989). The global score ranges from 0 to 69, where higher scores represent greater level of alcohol-related problems.
- Alcohol dependence [Change from baseline to week 5, and at 6 and 12 months post intervention.]
Alcohol dependence will be assessed with the Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (Grant et al., 2015).
Secondary Outcome Measures
- Drug use [Change from baseline to week 5, and at 6 and 12 months post intervention.]
Assessed with the Drug History Questionnaire (Sobell et al., 1995).
- Impulsiveness [Change from baseline to week 5, and at 6 and 12 months post intervention.]
Impulsiveness will be assessed with the Impulsive Behavior Scale (Cyders et al., 2014). The global score ranges from 20 to 80, where higher scores represent greater level of impulsivity.
- Sleep quality [Change from baseline to week 5, and at 6 and 12 months post intervention.]
Sleep will be assessed with different sleep measures, such as the Brief version of the Pittsburgh Sleep Quality Index (Sancho-Domingo et al., 2021). The global score of the B-PSQI ranges from 0 to 15, where higher scores represent poor sleep quality.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
16-18 years old.
-
Having inform consent from parents
-
Report using alcohol at least once a month during the previous last three months
Exclusion Criteria:
-
Participants will be excluded if they refer being diagnosed with a severe mental disorder.
-
Have a severe medical illness that will limit participation
-
Being under treatment for a psychological of psychiatric problem.
-
Meet DSM criteria for Drug dependence to illegal drugs.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | José Luis Carballo | Elche | Alicante | Spain | 03203 |
Sponsors and Collaborators
- Universidad Miguel Hernandez de Elche
- Spanish Ministry of Science, Innovation, and Universities
Investigators
- Principal Investigator: José Luis Carballo, PhD, Miguel Hernández University of Elche
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PID2019-110400RB-I00